Cargando…

Siponimod for multiple sclerosis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075740/
https://www.ncbi.nlm.nih.gov/pubmed/33911340
http://dx.doi.org/10.18773/austprescr.2021.014
_version_ 1783684578846703616
collection PubMed
description
format Online
Article
Text
id pubmed-8075740
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-80757402021-04-27 Siponimod for multiple sclerosis Aust Prescr New Drugs NPS MedicineWise 2021-04-01 2021-04 /pmc/articles/PMC8075740/ /pubmed/33911340 http://dx.doi.org/10.18773/austprescr.2021.014 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Siponimod for multiple sclerosis
title Siponimod for multiple sclerosis
title_full Siponimod for multiple sclerosis
title_fullStr Siponimod for multiple sclerosis
title_full_unstemmed Siponimod for multiple sclerosis
title_short Siponimod for multiple sclerosis
title_sort siponimod for multiple sclerosis
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075740/
https://www.ncbi.nlm.nih.gov/pubmed/33911340
http://dx.doi.org/10.18773/austprescr.2021.014